• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Bionor Holding AS

  • About us
  • Functional HIV cure
  • Products
  • Investors
  • News
  • Functional HIV cure
  • Vacc-4x vaccine
  • Vacc-C5 vaccine
  • Platform technology

News

News by the year

Bionor Pharma presents REDUC clinical trial results as a poster at GLOBVAC

Posted in Scientific 14.03.2017

The Research Council of Norway’s 10th Conference on Global Health and Vaccination Research where Bionor presents the Vacc-4x REDUC clinical trial results. The REDUC clinical trial was partly funded by […]


Bionor’s CSO Maja Sommerfelt was honorable speaker at Vaccines 2017

Posted in Scientific 21.02.2017

CSO Maja Sommerfelt was invited as an honorable speaker at Vaccines 2017 in Baltimore, USA, where she presented data from the REDUC clinical trial and chaired the session “HIV/AIDS Vaccines […]


Doctoral thesis at Oslo University Hospital based on clinical studies carried out in collaboration with Bionor Pharma

Posted in Scientific 7.12.2016

Oslo, 07.12.2016. Cand. Med. Kristin Brekke will defend her doctoral thesis entitled “Therapeutic vaccination in chronic HIV infection – clinical studies” on Thursday 8th December at Oslo University Hospital. Link […]


  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Interim pages omitted …
  • Go to page 22
  • Go to Next Page »

Which year do you want to read news?

  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010

    Footer

    • About us
    • Functional HIV cure
    • Products
    • Investors
    • News

    Bionor Holding AS
    Karenslysts Allé 6 – P.O. Box 4115 – NO-0217 Oslo – Norway
    [email protected]